949 resultados para Concerti grossi, Arranged.
Resumo:
In the whole of Europe the most important composer of concertos for two violins is indubitably Vivaldi (1678-1741), who produced almost thirty works of this type during almost the full length of his creative career. The dissertation examines this particular side of Vivaldi’s activity, starting with an examination of the concerto in Rome, Bologna, and Venice at the turn of the seventeenth and eighteenth centuries. The aspects investigated include the ‘conceptual’ origins of the double concerto for two violins in Vivaldi, the nature, distribution and interrelationship of their sources (particular attention being given to compositional revisions in the autograph manuscripts) and an analysis of the works themselves that takes in form, tonal structure, technical-instrumental character and performance practice. The concertos that have come down in particularly problematic non-autograph sources are discussed in detail and presented in critical editions. A reconstruction is offered of the two works (RV 520 and 526) that have survived only in incomplete form, lacking the part of the first soloist. The concertos for two violins composed in Germany by Telemann and J. S. Bach, the contemporaries of Vivaldi who paid greatest attention to the double concerto genre, are then described and analysed. The thesis ends with a complete list of modern editions of Vivaldi’s concertos for two violins and a select discography.
Resumo:
Prostate cancer (CaP) is the most commonly diagnosed malignancy in males in the Western world with one in six males diagnosed in their lifetime. Current clinical prognostication groupings use pathologic Gleason score, pre-treatment prostatic-specific antigen and Union for International Cancer Control-TNM staging to place patients with localized CaP into low-, intermediate- and high-risk categories. These categories represent an increasing risk of biochemical failure and CaP-specific mortality rates, they also reflect the need for increasing treatment intensity and justification for increased side effects. In this article, we point out that 30-50% of patients will still fail image-guided radiotherapy or surgery despite the judicious use of clinical risk categories owing to interpatient heterogeneity in treatment response. To improve treatment individualization, better predictors of prognosis and radiotherapy treatment response are needed to triage patients to bespoke and intensified CaP treatment protocols. These should include the use of pre-treatment genomic tests based on DNA or RNA indices and/or assays that reflect cancer metabolism, such as hypoxia assays, to define patient-specific CaP progression and aggression. More importantly, it is argued that these novel prognostic assays could be even more useful if combined together to drive forward precision cancer medicine for localized CaP.
Resumo:
by Samuel Lee
Resumo:
by Christian D. Ginsburg
Resumo:
comp. and ed. by Gershon Ephros
Resumo:
ed. and publ. by M. Goldstein ...
Resumo:
Signatur des Originals: S 36/F00610
Resumo:
Signatur des Originals: S 36/F00611
Resumo:
Signatur des Originals: S 36/F00612
Resumo:
Signatur des Originals: S 36/F00613
Resumo:
Signatur des Originals: S 36/F00614
Resumo:
Signatur des Originals: S 36/F00615
Resumo:
Signatur des Originals: S 36/G03100
Resumo:
Signatur des Originals: S 36/G03101
Resumo:
Fil: Nelli, María Florencia. Universidad Nacional de La Plata. Facultad de Humanidades y Ciencias de la Educación; Argentina.